marijuana stocks news

OrganiGram Holdings Inc. (OGRMF)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Feb 28, 2015 Nov 30, 2014 Jul 31, 2014 Apr 30, 2014
Total Revenue 142   12   –   –  
Cost of Revenue 27 6 – –
Gross Profit 115   6   –   –  
Operating Expenses
Research Development – – – –
Selling General and Administrative 539 723 177 24
Non Recurring – – – 2
Others – – – –
Total Operating Expenses – – – –
Operating Income or Loss (423) (718) (177) (26)
Income from Continuing Operations
Total Other Income/Expenses Net – – 5 –
Earnings Before Interest And Taxes (423) (718) (172) (25)
Interest Expense 23 – – –
Income Before Tax (446) (718) (172) (25)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (446) (718) (172) (25)
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (446) (718) (172) (25)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (446) (718) (172) (25)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$NTRR Develops Customer Awareness at CannaCon

NTRR Builds Customer Awareness at CannaCon Neutra Corp. (NTRR) representatives attended last…

$MJNA Innovates the MLM Industry With New Comp Plan

Kannaway, an MJNA Company, Innovates the MLM Industry With New Comp Plan…

AbbVie Inc. (ABBV) Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ®) Improved Clinical and Endoscopic Outcomes

Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ®) Improved Clinical and Endoscopic…

$LXRP to Change Name to Lexaria Bioscience Corp

Lexaria Proposes to Change Name to Lexaria Bioscience Corp  Lexaria, Corp. (LXRP)…